Omega Therapeutics (OMGA) Stock Chart & Stock Price History → Boost your retirement with these AI payouts (From InvestorPlace) (Ad) Free OMGA Stock Alerts $2.44 +0.03 (+1.24%) (As of 11:13 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Omega Therapeutics Stock Price Performance5 Day Performance+5.70%1 Month Performance+0.42%3 Month Performance-38.05%6 Month Performance+20.50%Year-To-Date Performance-19.93%1 Year Performance-72.77% Receive OMGA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some OMGA Stock Chart for Monday, May, 20, 2024 OMGA Chart by TradingView Omega Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.38$2.41+1.26%$2.49$2.35271,426 shs$132.91 million05/16/2024$2.28$2.38+4.39%$2.40$2.24195,187 shs$131.26 million05/15/2024$2.36$2.28-3.39%$2.45$2.22414,063 shs$125.74 million05/14/2024$2.36$2.36+0.21%$2.55$2.27426,797 shs$130.15 million05/13/2024$1.96$2.36+20.15%$2.52$1.98735,529 shs$129.88 million05/10/2024$2.17$1.96-9.68%$2.20$1.95518,857 shs$108.09 million Get the Latest News and Ratings for OMGA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.15$2.17+1.17%$2.24$2.11292,607 shs$119.68 million05/08/2024$2.16$2.15-0.46%$2.15$1.96490,605 shs$118.30 million05/07/2024$2.28$2.16-5.48%$2.36$2.15462,227 shs$118.85 million05/06/2024$2.58$2.28-11.63%$2.53$2.23578,447 shs$125.75 million05/03/2024$2.76$2.58-6.52%$3.00$2.56394,181 shs$142.29 million05/02/2024$2.48$2.76+11.29%$2.83$2.46695,776 shs$152.21 million05/01/2024$2.23$2.48+11.21%$2.59$2.25411,164 shs$136.77 million04/30/2024$2.29$2.23-2.62%$2.36$2.22187,168 shs$122.98 million04/29/2024$2.27$2.29+0.88%$2.36$2.26200,711 shs$126.29 million04/26/2024$2.35$2.27-3.40%$2.40$2.26257,322 shs$125.19 million04/25/2024$2.33$2.35+0.86%$2.37$2.20250,227 shs$129.60 million04/24/2024$2.34$2.33-0.43%$2.37$2.26200,062 shs$128.50 million04/23/2024$2.39$2.34-2.09%$2.54$2.32301,198 shs$129.05 million04/22/2024$2.40$2.39-0.42%$2.51$2.38193,038 shs$131.82 million04/19/2024$2.42$2.40-0.83%$2.45$2.35401,872 shs$132.36 million04/18/2024$2.56$2.42-5.28%$2.57$2.39363,603 shs$133.46 million04/17/2024$2.41$2.56+6.02%$2.62$2.39386,345 shs$140.91 million04/16/2024$2.52$2.41-4.17%$2.45$2.26448,155 shs$132.91 million04/15/2024$2.68$2.52-5.98%$2.69$2.51226,113 shs$138.70 million04/12/2024$2.96$2.68-9.63%$2.95$2.66252,658 shs$147.53 million04/11/2024$3.01$2.96-1.66%$3.00$2.91191,398 shs$163.24 million04/10/2024$3.02$3.01-0.33%$3.02$2.90379,928 shs$166.00 million04/09/2024$3.09$3.02-2.27%$3.16$2.98362,214 shs$166.55 million04/08/2024$2.95$3.09+4.75%$3.23$2.95477,344 shs$170.43 million04/05/2024$3.02$2.95-2.32%$3.08$2.93223,875 shs$162.69 million04/04/2024$2.89$3.02+4.68%$3.09$2.90538,225 shs$166.57 million04/03/2024$3.01$2.89-4.15%$3.01$2.85260,438 shs$159.11 million04/02/2024$3.20$3.01-5.94%$3.27$2.72704,436 shs$165.97 million04/01/2024$3.65$3.20-12.33%$3.63$3.16506,916 shs$176.45 million03/29/2024$3.65$3.65$3.77$3.59275,219 shs$201.26 million03/28/2024$3.55$3.65+2.82%$3.77$3.59274,990 shs$201.26 million03/27/2024$3.39$3.55+4.72%$3.57$3.33180,377 shs$195.75 million03/26/2024$3.41$3.39-0.59%$3.57$3.37206,962 shs$186.93 million03/25/2024$3.40$3.41+0.29%$3.60$3.38270,844 shs$188.03 millionHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs03/22/2024$3.57$3.40-4.76%$3.58$3.36161,248 shs$187.48 million03/21/2024$3.49$3.57+2.29%$3.73$3.51213,567 shs$196.85 million03/20/2024$3.43$3.49+1.75%$3.54$3.35239,817 shs$192.44 million03/19/2024$3.52$3.43-2.56%$3.57$3.35202,524 shs$189.14 million03/18/2024$3.62$3.52-2.76%$3.67$3.45354,156 shs$194.09 million03/15/2024$3.53$3.62+2.55%$3.70$3.56306,602 shs$199.61 million03/14/2024$3.91$3.53-9.72%$3.91$3.51414,936 shs$194.65 million03/13/2024$3.91$3.91$4.03$3.87169,790 shs$215.60 million03/12/2024$4.05$3.91-3.46%$4.09$3.87295,747 shs$215.60 million03/11/2024$4.11$4.05-1.46%$4.21$4.02254,814 shs$223.32 million03/08/2024$4.33$4.11-5.08%$4.44$4.09436,385 shs$226.63 million03/07/2024$4.05$4.33+6.91%$4.39$4.03510,143 shs$238.76 million03/06/2024$3.84$4.05+5.47%$4.11$3.83290,204 shs$223.32 million03/05/2024$4.14$3.84-7.25%$4.12$3.79411,941 shs$211.75 million03/04/2024$4.30$4.14-3.72%$4.39$4.02356,565 shs$228.28 million03/01/2024$4.11$4.30+4.62%$4.46$4.07634,675 shs$237.10 million02/29/2024$4.08$4.11+0.74%$4.25$4.01431,299 shs$226.63 million02/28/2024$4.22$4.08-3.32%$4.25$4.07407,098 shs$224.97 million02/27/2024$3.98$4.22+6.03%$4.24$3.95657,281 shs$232.69 million02/26/2024$3.69$3.98+7.86%$4.00$3.69426,145 shs$219.46 million02/23/2024$3.59$3.69+2.93%$3.80$3.55399,860 shs$203.47 million02/22/2024$3.61$3.59-0.69%$3.76$3.58576,300 shs$197.68 million02/21/2024$3.89$3.61-7.20%$3.89$3.59404,984 shs$199.06 million02/20/2024$4.29$3.89-9.32%$4.27$3.83714,908 shs$214.50 million02/19/2024$4.29$4.29$4.30$4.01747,600 shs$236.56 million Related Companies: Molecular Partners Stock Chart Karyopharm Therapeutics Stock Chart Scilex Stock Chart aTyr Pharma Stock Chart BioAtla Stock Chart Vigil Neuroscience Stock Chart Sangamo Therapeutics Stock Chart bluebird bio Stock Chart DBV Technologies Stock Chart Cardiol Therapeutics Stock Chart Receive OMGA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OMGA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldUrgent Nvidia WarningAltimetryDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.